NCT06436040View on ClinicalTrials.gov

Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

November 16, 2024

Study Completion Date

May 16, 2025

Conditions
Tumor MicroenvironmentLung Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Interventions
OTHER

Pathological response assessment

The pathological response classification in our study was based on the histopathologic examination of the surgically resected specimens reviewed by two experienced pathologists.

Trial Locations (1)

710038

RECRUITING

Hongtao Duan, Xi’an

All Listed Sponsors
lead

Tang-Du Hospital

OTHER